Lobo Tatiana T, Feijó Gilvania, Carvalho Sandra E, Costa Patrícia L, Chagas Carolina, Xavier Joaquim, Simoes-Barbosa Augusto
Program of Genomic Sciences and Molecular Biotechnology, Universidade Católica de Brasília, Brasília DF, Brazil.
Sex Transm Dis. 2003 Sep;30(9):694-9. doi: 10.1097/01.OLQ.0000079525.04451.05.
Trichomoniasis is the most prevalent nonviral sexually transmitted disease in humans worldwide. In addition to its pathologic implications, trichomoniasis is a risk factor for the transmission of the HIV and is associated with reproductive complications in females. Diagnosis of the disease is problematic due to inadequate accuracy of current diagnostic methods. Recently developed DNA-based techniques for detection of Trichomonas vaginalis seem to be promising alternatives.
The goal of this study was to evaluate the accuracy of the Papanicolaou test for the diagnosis of trichomoniasis by comparing polymerase chain reaction (PCR) with other current diagnostic methods.
A total of 1008 cervicovaginal swab specimens from a randomized population attending a gynecological service were analyzed in this study. In addition to current diagnostic methods, two sets of specific primers were used for PCR detection of T vaginalis in the cervicovaginal DNA samples, with a PCR quality control. Different examiners conducted PCR and Papanicolaou analyses in a double-blind trial.
The prevalence of trichomoniasis in this population was 6%. A considerable number of diagnostic results of the Papanicolaou test were false negative or false positive. Compared with PCR, specificity of the Papanicolaou test was 97.6%, whereas sensitivity was only 60.7%. The positive predictive value of the Papanicolaou smear was 61.7%. These results suggest that irregularly shaped parasites without clearly defined nuclei and flagella and bacteria-induced focal cytolysis limit the ability of the Papanicolaou test to detect T vaginalis.
The Papanicolaou test, the most readily available cytologic method for screening sexually transmitted pathogens and cellular abnormalities in most developing countries, is inadequate for the diagnosis of trichomoniasis due to its inherent limitations. However, PCR is a highly sensitive and specific test for the diagnosis of trichomoniasis.
滴虫病是全球范围内人类最常见的非病毒性传播疾病。除了其病理影响外,滴虫病还是艾滋病毒传播的危险因素,并且与女性生殖并发症有关。由于目前诊断方法的准确性不足,该疾病的诊断存在问题。最近开发的基于DNA的阴道毛滴虫检测技术似乎是有前景的替代方法。
本研究的目的是通过将聚合酶链反应(PCR)与其他当前诊断方法进行比较,评估巴氏试验诊断滴虫病的准确性。
本研究分析了来自一家妇科门诊随机人群的1008份宫颈阴道拭子标本。除了当前的诊断方法外,还使用两组特异性引物对宫颈阴道DNA样本中的阴道毛滴虫进行PCR检测,并进行PCR质量控制。不同的检查人员在双盲试验中进行PCR和巴氏分析。
该人群中滴虫病的患病率为6%。巴氏试验的相当数量的诊断结果为假阴性或假阳性。与PCR相比,巴氏试验的特异性为97.6%,而敏感性仅为60.7%。巴氏涂片的阳性预测值为61.7%。这些结果表明,形状不规则、细胞核和鞭毛不清晰的寄生虫以及细菌引起的局灶性细胞溶解限制了巴氏试验检测阴道毛滴虫的能力。
巴氏试验是大多数发展中国家筛查性传播病原体和细胞异常最容易获得的细胞学方法,但由于其固有的局限性,不足以诊断滴虫病。然而,PCR是诊断滴虫病的一种高度敏感和特异的检测方法。